Nanobiomaterials and Nanomedicines for Metabolic Disorders

Nanobiomaterials and Nanomedicines for Metabolic Disorders, 1st Edition, presents the application of nanotechnology and engineered nanobiomaterials to address metabolic disease mechanisms. The text details biomaterial synthesis alongside targeted drug delivery systems designed for specific metabolic pathways. It offers structured reference support for researchers, postgraduate students, and healthcare professionals operating across materials science, nanotechnology, endocrinology, and pharmaceutical science.

The content analyzes therapeutic strategies for widespread lifestyle-related conditions, including type 2 diabetes management, hyperlipidaemia, and obesity. In addition, the text reviews organic and inorganic nanoparticle formulations applied within medical imaging and diagnostic techniques to evaluate patient health and monitor underlying metabolic dysfunction.

A defining feature of the book is its dedicated coverage of specialized technical methods, including quantum dots, nanorobotics, and three-dimensional printing for managing metabolic disorders. Published by Elsevier, this 582-page volume equips advanced scholars and clinical specialists to examine nanoscale therapeutic platforms for practical research and clinical development.